ArticleAntimicrobial agents and chemotherapy2014

Ruxolitinib and tofacitinib are potent and selective inhibitors of HIV-1 replication and virus reactivation in vitro.

Christina Gavegnano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.